Clinical Trial Update: Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing safety and immune response of a rotavirus vaccine in HIV-infected and uninfected children born to HIV-infected mothers; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Rotavirus Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infection, Rotavirus Infection | Phase 2 | Status: COMPLETED | Results posted: 2015-07-22